N-heterocyclic inhibitors of TNF-ALPHA expression

Details for Australian Patent Application No. 2002316421 (hide)

Owner Pharmacopeia, Inc. Bristol-Myers Squibb Company

Inventors Ahmed, Gulzar; Diller, David J.; Metzger, Axel; Henderson, Ian; Wrobleski, Stephen T.; Leftheris, Katerina; Wen, James

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002316421

PCT Number PCT/US02/20341

PCT Pub. Number WO2003/002544

Priority 60/301,020 26.06.01 US

Filing date 26 June 2002

Wipo publication date 3 March 2003

Acceptance publication date 15 May 2008

International Classifications

C07D 213/85 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/06 (2006.01) Drugs for skeletal disorders

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 60/301,020 26.06.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002316421

15 May 2008 Application Accepted

  Published as AU-B-2002316421

11 September 2008 Standard Patent Sealed

27 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002316422-Wireless remote controlled mirror

2002316420-COMPOSITION AND METHOD FOR REDUCING ADVERSE INTERACTIONS BETWEEN PHENOTHIAZINE DERIVATIVES AND PLASMA